Connection

Fengcai Zhu to Glycoproteins

This is a "connection" page, showing publications Fengcai Zhu has written about Glycoproteins.
Connection Strength

0.114
  1. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2017 02 11; 389(10069):621-628.
    View in: PubMed
    Score: 0.114
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.